Skip to main content
T&F logoTaylor & Francis Group logoTaylor & Francis Group logo
Search all titles
  • Search all titles

  • Search all collections

  • Login
  • Hi, User  
    • Your Account

    • Logout

  • Search all titles
  • Search all collections
loading

Endocrine Therapy in Breast Cancer

DOI link for Endocrine Therapy in Breast Cancer

Endocrine Therapy in Breast Cancer book

Endocrine Therapy in Breast Cancer

DOI link for Endocrine Therapy in Breast Cancer

Endocrine Therapy in Breast Cancer book

ByWilliam R. Miller, James N. Ingle
Edition 1st Edition
First Published 2002
eBook Published 8 March 2002
Pub. location Boca Raton
Imprint CRC Press
DOI https://doi.org/10.1201/b14067
Pages 400 pages
eBook ISBN 9780429222108
SubjectsMedicine, Dentistry, Nursing & Allied Health
Share
Share

Get Citation

Miller, W., Ingle, J. (2002). Endocrine Therapy in Breast Cancer. Boca Raton: CRC Press, https://doi.org/10.1201/b14067

This reference evaluates and describes the latest strategies for hormone suppression and blockade in the management of early and advanced stage breast cancer and explores the effects of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their combination on both breast cancers and normal tissues.

Endocrine T

TABLE OF CONTENTS

chapter 1|14 pages

Why Endocrine Therapy?

ByDaniel F. Hayes

chapter 2|16 pages

Tamoxifen and Advanced Breast Cancer: An Overview

ByJohn F. Forbes

chapter 3|14 pages

Overview of Aromatase Inhibitors and Inactivators in the Treatment of Advanced Breast Cancer

ByPer Eystein Lønning

chapter 4|32 pages

Endocrine Treatment of Advanced Breast Cancer: Selective Estrogen-Receptor Modulators (SERMs)

ByStephen R. D. Johnston, Anthony Howell

chapter 5|46 pages

Other Endocrine and Biological Agents in the Treatment of Advanced Breast Cancer

ByJan G. M. Klijn, Els M. J. J. Berns, and John A. Foekens

chapter 6|10 pages

Early Breast Cancer: Tamoxifen Overview

ByCarsten Rose

chapter 7|10 pages

Aromatase Inhibitors and Early Breast Cancer

ByPaul E. Goss

chapter 8|12 pages

SERMs: Overview in Early Breast Cancer

ByIan E. Smith

chapter 9|24 pages

Surrogate and Intermediate Markers in Early Breast Cancer

ByMitch Dowsett

chapter 10|16 pages

Neoadjuvant Endocrine Therapy for Breast Cancer: A Medical Oncologist’s Perspective

ByMatthew J. Ellis

chapter 11|16 pages

Neoadjuvant Therapy: Surgical Perspectives

ByJ. Michael Dixon

chapter 12|10 pages

Pathology of Breast Cancer Following Neoadjuvant Endocrine Therapy

ByHironobu Sasano, Takashi Suzuki, and Takuya Moriya

chapter 13|8 pages

Neoadjuvant Therapy: Prediction of Response

ByWilliam R. Miller, T. J. Anderson, S. Iqbal, and J. Michael Dixon

chapter 14|36 pages

Mechanisms of Resistance to Endocrine Therapy

ByNancy E. Hynes

chapter 15|20 pages

Epidemiological Basis of Hormonal Chemoprevention of Breast Cancer

ByMalcolm C. Pike, John R. Daniels, and Darcy V. Spicer

chapter 16|16 pages

Breast Carcinogenesis and Its Prevention by Inhibition of Estrogen Genotoxicity

ByJoachim G. Liehr

chapter 17|6 pages

Use of Selective Antiestrogens for the Chemoprevention of Breast Cancer

ByTrevor J. Powles

chapter 18|56 pages

Aromatase Inhibitors and Chemoprevention of Breast Cancer

ByPaul E. Goss
T&F logoTaylor & Francis Group logo
  • Policies
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
  • Journals
    • Taylor & Francis Online
    • CogentOA
    • Taylor & Francis Online
    • CogentOA
  • Corporate
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
  • Help & Contact
    • Students/Researchers
    • Librarians/Institutions
    • Students/Researchers
    • Librarians/Institutions

Connect with us

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG © 2019 Informa UK Limited